Brian M Culley Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity

Brian M Culley is President and CEO of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 222,135 shares of LCTX, which is worth approximately $422,056. The most recent transaction as insider was on Mar 31, 2021, when has been sold 15,450 shares (Common Shares, no par value) at a price of $2.35 per share, resulting in proceeds of $36,307. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 222K

4.02% 3M change

14.01% 12M change

Total Value Held $422,056

Brian M Culley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2021	BUY Exercise of conversion of derivative security	$36,307 $2.35 p/Share	15,450 Added 7.14%	201,052 Common Shares, no par ...
Dec 31 2020	SELL Payment of exercise price or tax liability	$9,404 $1.76 p/Share	5,343 Reduced 2.8%	185,602 Common Shares, no par ...
Dec 31 2020	BUY Exercise of conversion of derivative security	$27,192 $1.76 p/Share	15,450 Added 7.49%	190,945 Common Shares, no par ...
Sep 30 2020	SELL Payment of exercise price or tax liability	$5,022 $0.94 p/Share	5,343 Reduced 2.95%	175,495 Common Shares, no par ...
Sep 30 2020	BUY Exercise of conversion of derivative security	$14,523 $0.94 p/Share	15,450 Added 7.87%	180,838 Common Shares, no par ...

BMC

Brian M Culley

President and CEO

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Value

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Lineage Cell Therapeutics, Inc.

Track Activities on LCTX

Account